Accessibility Menu
Anteris Technologies Ltd logo

Anteris Technologies Ltd(ASX) AVR

Market CapA$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-83%
5 Year+17%
1 Year-47%
1 Month+3%
A$11.75
-1.34%
-0.16Today
Anteris Technologies Ltd last closing stock price
MetricPriceDate
Last closeAUD 10.542024-12-05
Anteris Technologies Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.46%AUD 9.902024-11-28
1 month+3.33%AUD 10.202024-11-05
3 month+5.51%AUD 9.992024-09-06
Year to date-44.96%AUD 19.152023-12-29
1 year-46.77%AUD 19.802023-12-06
3 year+25.48%AUD 8.402021-12-03
5 year+17.11%AUD 9.002019-12-06
Since inception-83.04%AUD 70.232011-06-27

Anteris Technologies Ltd Financials at a Glance

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.51M

Net Income (TTM)

-$180.35M

EPS (TTM)

A$0.00

P/E Ratio

-2.09

Dividend

A$0.00

Beta (Volatility)

-17.05 (Low)

Price

A$11.75

Volume

14,270

Open

A$11.68

Previous Close

A$11.91

Daily Range

A$11.43 - A$11.75

52-Week Range

A$5.20 - A$23.93

Estimated Earnings Date

Aug 17, 2026

AVR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anteris Technologies Ltd

Anteris Technologies Ltd is a healthcare company focused on the structural heart domain, specializing in innovative medical devices. The firm is known for its ADAPT technology and the DurAVR™ aortic valve, aimed at treating aortic stenosis.

Products and Services
  • ADAPT technology based on regenerative tissue
  • DurAVR™, a 3D single-component aortic valve
  • Research and development in regenerative medicines
Growth Outlook
  • Significant advancements in aortic valve technology expected to drive market demand
  • Increased investment in R&D to enhance product offerings
  • Strategic partnerships may expand market reach and capabilities
Financial Highlights
  • Recent quarterly revenue of 1,504,099, showing growth potential
  • Cash and cash equivalents of 257,054,961, providing financial stability
  • Current ratio of 14.20 indicates strong liquidity position
Anteris Technologies Ltd operates in a promising sector with a focus on innovative solutions for heart-related conditions. The company's commitment to research and development positions it well for future growth, particularly with its advanced aortic valve technology. Recent financial data reflects a solid cash position, which may support ongoing development and operational needs. The strategic focus on partnerships and expanding product lines could further enhance its market presence, making it an intriguing option for investors interested in the healthcare technology sector.
AI Generated • Aug 21, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Toowong, QLD 4066, AU

AVR Financials

Key Financial Metrics (TTM)

Gross Margin

72.55%

Operating Margin

-4574.84%

Net Income Margin

-4482.38%

Return on Equity

-99.78%

Return on Capital

-4289.36%

Return on Assets

-46.01%

Earnings Yield

-47.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

21.14M

Volume

14.27K

Avg. Volume

28.78K

Financials (TTM)

Gross Profit

$2.99M

Operating Income

-$184.69M

EBITDA

-$180.96M

Operating Cash Flow

-$97.65M

Capital Expenditure

-$3.12M

Free Cash Flow

-$100.77M

Cash & ST Invst.

$257.05M

Total Debt

$3.32M

Anteris Technologies Ltd Performance Analysis

Anteris Technologies Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-38.6%
Q22025-06-30-69.0%
Q42025-12-31219.8%
Q22026-06-3016.1%
Anteris Technologies Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3132.0%
Q22025-06-3079.7%
Q42025-12-31-434.2%
Q22026-06-3071.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.50M

-29.3%

Gross Profit

$1.16M

+22.0%

Gross Margin

76.91%

N/A

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.28M

N/A

Employees

174

N/A

Net Income

-$52.16M

-2.6%

EBITDA

-$54.15M

-5.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$257.05M

+2270.4%

Total Debt

$3.32M

+20.3%

Accounts Receivable

$548.40K

-67.1%

Inventory

$8.01K

-98.6%

Long Term Debt

$2.30M

+55.6%

Short Term Debt

$1.03M

-20.1%

Return on Assets

-46.01%

N/A

Return on Invested Capital

-50.35%

N/A

Free Cash Flow

-$50.30M

-11.8%

Operating Cash Flow

-$49.51M

-15.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARX.AXAroa Biosurgery Limited
A$0.54-1.82%
EMV.AXEMVision Medical Devices Ltd
A$1.76+1.45%
MVF.AXMonash IVF Group Limited
A$0.77+1.99%
AVH.AXAVITA Medical, Inc.
A$2.80+1.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$224.41+0.03%
PCGPG&E
$13.33-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.37+0.00%
NUNu Holdings
$15.40+0.07%

Questions About AVR

What is the current price of Anteris Technologies Ltd?

Anteris Technologies Ltd is trading at A$11.75 per share.

What is the 52-week range for Anteris Technologies Ltd?

Over the past 52 weeks, Anteris Technologies Ltd has traded between A$5.20 and A$23.93.

How much debt does Anteris Technologies Ltd have?

Anteris Technologies Ltd total debt is unavailable.

How much cash does Anteris Technologies Ltd have on hand?

Anteris Technologies Ltd does not have cash on hand data available.

What is Anteris Technologies Ltd’s dividend yield?

Anteris Technologies Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.